Risk-based decision making: a good start to aiding US blood policy decisions?

Transfusion

Volumn 58, Issue 8, 2018, Pages 1827-1830

  Shaz, Beth H ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BABESIA; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; DISEASE TRANSMISSION; EDITORIAL; ENDEMIC DISEASE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; MEDICAL DECISION MAKING; NONHUMAN; RISK; RISK MANAGEMENT; RISK-BASED DECISION MAKING; UNITED STATES; DECISION MAKING;

BABESIA; DECISION MAKING; UNITED STATES;

EID: 85052951684     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14927     Document Type: Editorial

References (16)

1. Ward S, Stramer S, Szczepiorkowski Z. Assessing the risk of Babesia to the US blood supply using a risk-based decision-making approach (RBDM). Report of AABB's Ad Hoc Babesia Policy Working Group. Transfusion 2018;58:••••-••.
2. Blood & blood products [Internet]. Silver Spring (MD): US Food and Drug Administration; 2018 [cited 2018 Aug 24]. Available from: https://www.fda.gov/biologicsbloodvaccines/bloodbloodproducts/.
3. Alliance of Blood Operators. Risk-based decision-making framework for blood safety [Internet]. 2014 [cited 2018 Aug 24]. Available from: https://www.allianceofbloodoperators.org/media/101766/ABO-Risk-based-decision-making-framework-for-blood-safety-for-consultation.pdf.
4. Leach Bennett J, Blajchman MA, Delage G, et al. Proceedings of a consensus conference: risk-based decision making for blood safety. Transfus Med Rev 2011;25:267-92.
5. Stein J, Besley J, Brook C, et al. Risk-based decision-making for blood safety: preliminary report of a consensus conference. Vox Sang 2011;101:277-81.
6. Herwaldt BL, Linden JV, Bosserman E, et al. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011;155:509-19.
7. Burgess MJ, Rosenbaum ER, Pritt BS, et al. Possible transfusion-transmitted Babesia divergens-like/MO-1 infection in an Arkansas patient. Clin Infect Dis 2017;64:1622-5.
8. Recommendation for reducing the risk of transfusion-transmitted babesiosis: draft guidance for industry [Internet]. Silver Spring (MD): US Food and Drug Administration; 2018 [cited 2018 Aug 24]. Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM614734.pdf.
9. Surveillance for Babesiosis—United States, 2014. Annual summary [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2016 [cited 2018 Aug 24]. Available from: https://www.cdc.gov/parasites/babesiosis/resources/babesiosis_surveillance_summary_2016.pdf.
10. Linden JV, Prusinski MA, Crowder LA, et al. Transfusion-transmitted and community-acquired babesiosis in New York, 2004 to 2015. Transfusion 2018;58:660-8.
11. Nieto NC, Porter WT, Wachara JC, et al. Using citizen science to describe the prevalence and distribution of tick bite and exposure to tick-borne diseases in the United States. PLoS One 2018;13:e0199644.
12. Tickborne diseases of the United States: a reference manual for health care providers: fourth edition, 2017 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2017 [cited 2018 Aug 24]. Available from: https://www.cdc.gov/lyme/resources/TickborneDiseases.pdf.
13. Fang DC, McCullough J. Transfusion-transmitted Babesia microti. Transfus Med Rev 2016;30:132-8.
14. Tonnetti L, Laughhunn A, Thorp AM, et al. Inactivation of Babesia microti in red blood cells and platelet concentrates. Transfusion 2017;57:2404-12.
15. Tonnetti L, Proctor MC, Reddy HL, et al. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion 2010;50:1019-27.
16. Castro E, Gonzalez LM, Rubio JM, et al. The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat platelets. Transfusion 2014;54:2207-16.